MicroRNAs of Epstein-Barr Virus Control Innate and Adaptive Antiviral Immunity-Reference-Cited by-同舟云学术

MicroRNAs of Epstein-Barr Virus Control Innate and Adaptive Antiviral Immunity

Published:2017-08-15 Issue:16 Volume:91 Page:
ISSN:0022-538X
Container-title:Journal of Virology
language:en
Short-container-title:J Virol

Author:

Albanese Manuel¹^ORCID,Tagawa Takanobu¹^ORCID,Buschle Alexander¹,Hammerschmidt Wolfgang¹^ORCID

Affiliation:

1. Research Unit Gene Vectors, Helmholtz Zentrum München, German Research Center for Environmental Health and German Centre for Infection Research (DZIF), Partner site Munich, Munich, Germany

Abstract

ABSTRACT Epstein-Barr virus (EBV) has established lifelong infection in more than 90% of humanity. While infection is usually controlled by the immune system, the human host fails to completely eliminate the pathogen. Several herpesviral proteins are known to act as immunoevasins, preventing or reducing recognition of EBV-infected cells. Only recently were microRNAs of EBV identified to reduce immune recognition further. This Gem summarizes what we know about immunomodulatory microRNAs of herpesviruses.

Funder

HHS | NIH | National Cancer Institute

Deutsche Forschungsgemeinschaft

Deutsche Krebshilfe

Deutscher Akademischer Austauschdienst

Publisher

American Society for Microbiology

Subject

Virology,Insect Science,Immunology,Microbiology

Link

https://journals.asm.org/doi/pdf/10.1128/JVI.01667-16

Reference44 articles.